SPATA31C2
gene geneOn this page
Also known as DKFZP434M131
Summary
SPATA31C2 (SPATA31 subfamily C member 2, HGNC:24508) is a protein-coding gene on chromosome 9q22.1, encoding Spermatogenesis-associated protein 31C2 (B4DYI2). May play a role in spermatogenesis.
Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 645961 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 18 total
- MANE Select transcript:
NM_001350978
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24508 |
| Approved symbol | SPATA31C2 |
| Name | SPATA31 subfamily C member 2 |
| Location | 9q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434M131 |
| Ensembl gene | ENSG00000177910 |
| Ensembl biotype | protein_coding |
| Entrez | 645961 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000324915, ENST00000675441
RefSeq mRNA: 2 — MANE Select: NM_001350978
NM_001166137, NM_001350978
CCDS: CCDS94435, CCDS94436
Canonical transcript exons
ENST00000324915 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003324058 | 88138258 | 88138475 |
| ENSE00003642713 | 88132966 | 88133026 |
| ENSE00003899321 | 88133594 | 88133669 |
| ENSE00003903861 | 88129305 | 88132710 |
Expression profiles
Bgee: expression breadth broad, 18 present calls, max score 83.09.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.09 | gold quality |
| right testis | UBERON:0004534 | 79.40 | gold quality |
| left testis | UBERON:0004533 | 79.15 | gold quality |
| testis | UBERON:0000473 | 78.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.90 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.21 | gold quality |
| bone marrow cell | CL:0002092 | 42.97 | gold quality |
| endometrium | UBERON:0001295 | 42.50 | gold quality |
| duodenum | UBERON:0002114 | 41.91 | silver quality |
| Ammon’s horn | UBERON:0001954 | 41.49 | gold quality |
| bone marrow | UBERON:0002371 | 41.43 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 40.67 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 40.11 | silver quality |
| vermiform appendix | UBERON:0001154 | 37.82 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.16 | gold quality |
| lymph node | UBERON:0000029 | 36.79 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| fallopian tube | UBERON:0003889 | 36.15 | gold quality |
| cerebral cortex | UBERON:0000956 | 35.95 | gold quality |
| primary visual cortex | UBERON:0002436 | 35.88 | gold quality |
| sural nerve | UBERON:0015488 | 35.50 | gold quality |
| right uterine tube | UBERON:0001302 | 35.40 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 35.11 | gold quality |
| rectum | UBERON:0001052 | 34.59 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 34.29 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| cortex of kidney | UBERON:0001225 | 33.22 | gold quality |
| temporal lobe | UBERON:0001871 | 33.09 | gold quality |
| endocervix | UBERON:0000458 | 32.85 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.97 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting SPATA31C2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-670-3P | 99.03 | 68.88 | 2404 |
| HSA-MIR-3164 | 99.02 | 68.39 | 1071 |
| HSA-MIR-6820-3P | 99.02 | 68.50 | 1035 |
| HSA-MIR-758-3P | 98.42 | 68.60 | 1122 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
| HSA-MIR-3118 | 97.11 | 66.58 | 984 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-3059-3P | 96.71 | 67.08 | 606 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
| HSA-MIR-1238-3P | 95.27 | 62.25 | 552 |
| HSA-MIR-4513 | 95.04 | 67.06 | 727 |
| HSA-MIR-6855-3P | 95.04 | 66.57 | 725 |
| HSA-MIR-4520-5P | 93.54 | 65.23 | 140 |
| HSA-MIR-1537-3P | 90.51 | 63.57 | 105 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata31 | ENSMUSG00000056223 |
| rattus_norvegicus | Spata31 | ENSRNOG00000018202 |
Paralogs (13): SPATA31E1 (ENSG00000177992), SPATA31A6 (ENSG00000185775), SPATA31D3 (ENSG00000186788), SPATA31F3 (ENSG00000187791), SPATA31D4 (ENSG00000189357), SPATA31A1 (ENSG00000204849), SPATA31F1 (ENSG00000205108), SPATA31D1 (ENSG00000214929), SPATA31C1 (ENSG00000230246), (ENSG00000251545), SPATA31A3 (ENSG00000275969), SPATA31A7 (ENSG00000276040), SPATA31A5 (ENSG00000276581)
Protein
Protein identifiers
Spermatogenesis-associated protein 31C2 — B4DYI2 (reviewed: B4DYI2)
Alternative names: Protein FAM75C2
All UniProt accessions (2): B4DYI2, A0A8I5KWQ5
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Similarity. Belongs to the SPATA31 family.
RefSeq proteins (2): NP_001159609, NP_001337907* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027970 | SPATA31-like | Domain |
| IPR039509 | SPATA31 | Domain |
Pfam: PF14650, PF15371
UniProt features (19 total): compositionally biased region 10, region of interest 7, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B4DYI2-F1 | 40.46 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GOBP_MALE_GAMETE_GENERATION, chr9q22, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, MIR3059_5P, MIR345_3P, MIR1343_5P, MIR939_5P, MIR6857_5P, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN, GOBP_SEXUAL_REPRODUCTION, GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN, GOBP_REPRODUCTIVE_PROCESS
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096LP49, A6NGG8, A6NNH2, B1ASB6, B4DYI2, B6VQA5, C0HKD1, C0HKD2, C0HKD3, D2J0Y4, D6RGX4, E9QAF0, P0C874, P0DKV0, Q149B8, Q3KR64, Q4R736, Q4V8B5, Q5TZJ5, Q5VU36, Q5VVP1, Q5VWK0, Q5VYM1, Q5VYP0, Q63HN1, Q658T7, Q68A65, Q6NS69, Q6NXZ1, Q6PAC4, Q6ZQQ2, Q6ZU69, Q6ZUB0, Q6ZUB1, Q7TSA6, Q80X53, Q86Y26, Q8BHP2, Q8BHW6, Q8C0D9
Diamond homologs: B4DYI2, B6VQA5, E9QAF0, P0C874, P0DKV0, Q5TZJ5, Q5VU36, Q5VVP1, Q5VYP0, Q6ZQQ2, Q6ZUB0, Q6ZUB1, Q8IWB4, C0HKD1, C0HKD2, C0HKD3, Q642A3, A6NFR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
7374 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000910880 (9:88137988 G>A,C), RS1001263149 (9:88138849 C>A,G), RS1001874619 (9:88131395 C>T), RS1001979859 (9:88137770 G>A), RS1003657405 (9:88135008 G>A), RS1004891327 (9:88133956 A>C), RS1004942179 (9:88133861 G>A,T), RS1005229951 (9:88133333 C>G,T), RS1007787135 (9:88132586 C>T), RS1008235059 (9:88140117 A>C), RS1008288852 (9:88138909 A>G), RS1008568502 (9:88136734 A>G), RS1008584627 (9:88131728 A>G), RS1008624379 (9:88135726 C>A,T), RS1009356133 (9:88138794 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005024_42 | Pursuit maintenance gain | 6.000000e-07 |
| GCST006680_1 | Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test) | 2.000000e-06 |
| GCST008839_235 | Height | 1.000000e-10 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008433 | pursuit maintenance gain measurement |
| EFO:0003959 | cleft lip |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.